FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2968036716> ?p ?o ?g. }

• W2968036716 endingPage "919" @default.
• W2968036716 startingPage "911" @default.
• W2968036716 abstract "Objective To fulfil an unmet therapeutic need for treating type 2 diabetes by developing an innovative oral drug delivery nanosystem increasing the production of glucagon-like peptide-1 (GLP-1) and the absorption of peptides into the circulation. Design We developed a nanocarrier for the oral delivery of peptides using lipid-based nanocapsules. We encapsulated the GLP-1 analogue exenatide within nanocapsules and investigated in vitro in human L-cells (NCl-H716) and murine L-cells (GLUTag cells) the ability of the nanosystem to trigger GLP-1 secretion. The therapeutic relevance of the nanosystem in vivo was tested in high-fat diet (HFD)-induced diabetic mice following acute (one administration) or chronic treatment (5 weeks) in obese and diabetic mice. Results We demonstrated that this innovative nanosystem triggers GLP-1 secretion in both human and murine cells as well as in vivo in mice. This strategy increases the endogenous secretion of GLP-1 and the oral bioavailability of the GLP-1 analogue exenatide (4% bioavailability with our nanosystem). The nanosystem synergizes its own biological effect with the encapsulated GLP-1 analogue leading to a marked improvement of glucose tolerance and insulin resistance (acute and chronic). The chronic treatment decreased diet-induced obesity, fat mass, hepatic steatosis, together with lower infiltration and recruitment of immune cell populations and inflammation. Conclusion We developed a novel nanosystem compatible with human use that synergizes its own biological effect with the effects of increasing the bioavailability of a GLP-1 analogue. The effects of the formulation were comparable to the results observed for the marketed subcutaneous formulation. This nanocarrier-based strategy represents a novel promising approach for oral peptide delivery in incretin-based diabetes treatment." @default.
• W2968036716 created "2019-08-22" @default.
• W2968036716 creator A5001987906 @default.
• W2968036716 creator A5012685147 @default.
• W2968036716 creator A5034456412 @default.
• W2968036716 creator A5042192451 @default.
• W2968036716 creator A5070336660 @default.
• W2968036716 creator A5085161505 @default.
• W2968036716 date "2019-08-10" @default.
• W2968036716 modified "2023-10-18" @default.
• W2968036716 title "Novel strategy for oral peptide delivery in incretin-based diabetes treatment" @default.
• W2968036716 cites W1205374584 @default.
• W2968036716 cites W1983581467 @default.
• W2968036716 cites W2006474213 @default.
• W2968036716 cites W2008869160 @default.
• W2968036716 cites W2045681126 @default.
• W2968036716 cites W2046315492 @default.
• W2968036716 cites W2051759959 @default.
• W2968036716 cites W2067306688 @default.
• W2968036716 cites W2076633494 @default.
• W2968036716 cites W2080410583 @default.
• W2968036716 cites W2084948079 @default.
• W2968036716 cites W2095915493 @default.
• W2968036716 cites W2125372126 @default.
• W2968036716 cites W2138411980 @default.
• W2968036716 cites W2140853326 @default.
• W2968036716 cites W2146281387 @default.
• W2968036716 cites W2168526937 @default.
• W2968036716 cites W2205256123 @default.
• W2968036716 cites W2284082872 @default.
• W2968036716 cites W2293947812 @default.
• W2968036716 cites W2551534702 @default.
• W2968036716 cites W2557058169 @default.
• W2968036716 cites W2606455926 @default.
• W2968036716 cites W2770217892 @default.
• W2968036716 cites W2773499331 @default.
• W2968036716 cites W2883953772 @default.
• W2968036716 cites W2914171609 @default.
• W2968036716 cites W2914227154 @default.
• W2968036716 cites W4249727000 @default.
• W2968036716 doi "https://doi.org/10.1136/gutjnl-2019-319146" @default.
• W2968036716 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7229891" @default.
• W2968036716 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31401561" @default.
• W2968036716 hasPublicationYear "2019" @default.
• W2968036716 type Work @default.
• W2968036716 sameAs 2968036716 @default.
• W2968036716 citedByCount "37" @default.
• W2968036716 countsByYear W29680367162019 @default.
• W2968036716 countsByYear W29680367162020 @default.
• W2968036716 countsByYear W29680367162021 @default.
• W2968036716 countsByYear W29680367162022 @default.
• W2968036716 countsByYear W29680367162023 @default.
• W2968036716 crossrefType "journal-article" @default.
• W2968036716 hasAuthorship W2968036716A5001987906 @default.
• W2968036716 hasAuthorship W2968036716A5012685147 @default.
• W2968036716 hasAuthorship W2968036716A5034456412 @default.
• W2968036716 hasAuthorship W2968036716A5042192451 @default.
• W2968036716 hasAuthorship W2968036716A5070336660 @default.
• W2968036716 hasAuthorship W2968036716A5085161505 @default.
• W2968036716 hasBestOaLocation W29680367161 @default.
• W2968036716 hasConcept C134018914 @default.
• W2968036716 hasConcept C150903083 @default.
• W2968036716 hasConcept C155672457 @default.
• W2968036716 hasConcept C171250308 @default.
• W2968036716 hasConcept C181389837 @default.
• W2968036716 hasConcept C18150654 @default.
• W2968036716 hasConcept C185592680 @default.
• W2968036716 hasConcept C192562407 @default.
• W2968036716 hasConcept C204399865 @default.
• W2968036716 hasConcept C207001950 @default.
• W2968036716 hasConcept C2777180221 @default.
• W2968036716 hasConcept C2778881409 @default.
• W2968036716 hasConcept C2780035454 @default.
• W2968036716 hasConcept C2780533449 @default.
• W2968036716 hasConcept C555293320 @default.
• W2968036716 hasConcept C71924100 @default.
• W2968036716 hasConcept C86803240 @default.
• W2968036716 hasConcept C98274493 @default.
• W2968036716 hasConceptScore W2968036716C134018914 @default.
• W2968036716 hasConceptScore W2968036716C150903083 @default.
• W2968036716 hasConceptScore W2968036716C155672457 @default.
• W2968036716 hasConceptScore W2968036716C171250308 @default.
• W2968036716 hasConceptScore W2968036716C181389837 @default.
• W2968036716 hasConceptScore W2968036716C18150654 @default.
• W2968036716 hasConceptScore W2968036716C185592680 @default.
• W2968036716 hasConceptScore W2968036716C192562407 @default.
• W2968036716 hasConceptScore W2968036716C204399865 @default.
• W2968036716 hasConceptScore W2968036716C207001950 @default.
• W2968036716 hasConceptScore W2968036716C2777180221 @default.
• W2968036716 hasConceptScore W2968036716C2778881409 @default.
• W2968036716 hasConceptScore W2968036716C2780035454 @default.
• W2968036716 hasConceptScore W2968036716C2780533449 @default.
• W2968036716 hasConceptScore W2968036716C555293320 @default.
• W2968036716 hasConceptScore W2968036716C71924100 @default.
• W2968036716 hasConceptScore W2968036716C86803240 @default.
• W2968036716 hasConceptScore W2968036716C98274493 @default.
• W2968036716 hasFunder F4320321390 @default.
• W2968036716 hasFunder F4320326486 @default.

• next